Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

18.3 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -201.592-197.723-143.883-129.068-255.131-1.288
Depreciation & Amortization 0.5750.620.5210.3230.0080
Deferred Income Tax 4.66900-0.09596.2720
Stock Based Compensation 45.02524.13316.8125.840.4060
Change In Working Capital -13.6445.438-27.47551.717-9.5220.215
Accounts Receivables -1.63700000
Inventory -9.44200000
Accounts Payables 6.418.679-9.79124.0092.2650.225
Other Working Capital -8.975-3.241-17.68427.708-11.787-0.01
Other Non Cash Items 27.38721.0025.4081.595131.4570.05
Operating Cash Flow -137.58-146.53-148.617-69.688-36.51-1.023
Investing Activities:
Investments In Property Plant And Equipment -1.634-1.041-0.328-1.04-25.250
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites -1.652-1.179-0.33-1.185-25.1180
Investing Cash Flow -1.634-1.041-0.328-1.04-25.250
Financing Activities:
Debt Repayment -211.993-95.446-54.125-25-113.174-1.9
Common Stock Issued 155.58724.5961.2988.83191.4720.002
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 172.675190.89297.54350.629226.3481.9
Financing Cash Flow 367.58120.04244.708114.459304.6461.902
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 228.366-27.529-104.23743.731242.8860.879
Cash At End Of Period 384.256155.89183.259287.496243.7650.879